Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 5,213 | 5,824 | 4,913 | 224 | 0 |
| Gross Profit | 5,213 | 5,824 | 4,913 | 224 | N/A |
| Operating Expenses | 20,511 | 20,519 | 18,234 | 19,936 | 12,492 |
| Operating Income | -15,298 | -14,695 | -13,321 | -19,712 | -12,492 |
| Interest Expense | 548 | 179 | 395 | 711 | 932 |
| Other Income | -6,540 | 1,896 | 400 | 148 | 25 |
| Pre-tax Income | -22,386 | -12,978 | -13,316 | -20,275 | -13,399 |
| Net Income Continuous | -22,386 | -12,978 | -13,316 | -20,275 | -13,399 |
| Net Income | $-22,386 | $-12,978 | $-13,316 | $-20,275 | $-13,399 |
| EPS Basic Total Ops | -7.25 | -48.75 | -106.00 | -289.50 | -416.04 |
| EPS Basic Continuous Ops | -7.19 | -48.86 | -105.99 | -289.64 | -415.43 |
| EPS Diluted Total Ops | -7.25 | -58.50 | -106.00 | -289.50 | -416.04 |
| EPS Diluted Continuous Ops | -7.19 | -42.13 | -105.99 | -289.64 | -415.43 |
| EPS Diluted Before Non-Recurring Items | -7.25 | -60.75 | -106.00 | -4,326.92 | -6,237.51 |
| EBITDA(a) | $-14,853 | $-13,823 | $-12,503 | $-18,704 | $-11,551 |